Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature

IF 0.6 Q4 CLINICAL NEUROLOGY Journal of Neurological Surgery Reports Pub Date : 2022-02-01 DOI:10.1055/s-0042-1749389
Isabella L. Pecorari, L. Mahali, A. Funari, R. Fecher, Nisha Suda, V. Agarwal
{"title":"Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature","authors":"Isabella L. Pecorari, L. Mahali, A. Funari, R. Fecher, Nisha Suda, V. Agarwal","doi":"10.1055/s-0042-1749389","DOIUrl":null,"url":null,"abstract":"Clinically silent double pituitary adenomas consisting of corticotroph and somatotroph cells are an exceedingly rare clinical finding. In this report, we present the case of a 28-year-old man with a 1-year history of recurrent headaches. Imaging revealed a 2.1 (anterior-posterior) × 2.2 (transverse) × 1.3 (craniocaudal) cm pituitary adenoma invading into the left cavernous sinus and encasing the left internal carotid artery. Endoscopic transnasal resection was performed without complications. Immunohistochemical staining revealed a double adenoma consisting of distinct sparsely granulated somatotroph and densely granulated corticotroph cells that were positive for growth hormone and adrenocorticotropic hormone, respectively. K i -67 index labeling revealed a level of 6% within the corticotroph adenoma. No increase in serum growth hormone or adrenocorticotropic hormone was found, indicating a clinically silent double adenoma. While transsphenoidal surgery remains a first-line approach for silent adenomas presenting with mass effects, increased rates of proliferative markers, such as the K i -67 index, provide useful insight into the clinical course of such tumors. Determining the K i -67 index of silent pituitary adenomas could be valuable in predicting recurrence after initial surgical resection and identifying tumors that are at an increased risk of needing additional therapeutic interventions or more frequent surveillance imaging.","PeriodicalId":44256,"journal":{"name":"Journal of Neurological Surgery Reports","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurological Surgery Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1749389","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Clinically silent double pituitary adenomas consisting of corticotroph and somatotroph cells are an exceedingly rare clinical finding. In this report, we present the case of a 28-year-old man with a 1-year history of recurrent headaches. Imaging revealed a 2.1 (anterior-posterior) × 2.2 (transverse) × 1.3 (craniocaudal) cm pituitary adenoma invading into the left cavernous sinus and encasing the left internal carotid artery. Endoscopic transnasal resection was performed without complications. Immunohistochemical staining revealed a double adenoma consisting of distinct sparsely granulated somatotroph and densely granulated corticotroph cells that were positive for growth hormone and adrenocorticotropic hormone, respectively. K i -67 index labeling revealed a level of 6% within the corticotroph adenoma. No increase in serum growth hormone or adrenocorticotropic hormone was found, indicating a clinically silent double adenoma. While transsphenoidal surgery remains a first-line approach for silent adenomas presenting with mass effects, increased rates of proliferative markers, such as the K i -67 index, provide useful insight into the clinical course of such tumors. Determining the K i -67 index of silent pituitary adenomas could be valuable in predicting recurrence after initial surgical resection and identifying tumors that are at an increased risk of needing additional therapeutic interventions or more frequent surveillance imaging.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无症状性促皮质性和促生长性双垂体腺瘤1例报告及文献复习
由促肾上腺皮质激素和生长激素细胞组成的临床无症状双垂体腺瘤是一种极为罕见的临床发现。在本报告中,我们报告了一例28岁的男性,有1年的复发性头痛病史。影像学检查显示2.1(前后) × 2.2(横向) × 1.3(头尾侧)cm垂体腺瘤侵犯左侧海绵窦并包裹左侧颈内动脉。经鼻内镜切除术无并发症。免疫组织化学染色显示一个双腺瘤,由稀疏颗粒的生长激素细胞和密集颗粒的促肾上腺皮质激素细胞组成,分别对生长激素和促肾上腺皮质素呈阳性。KI-67指数标记显示在促肾上腺皮质激素腺瘤内的水平为6%。没有发现血清生长激素或促肾上腺皮质激素增加,表明临床上无症状的双腺瘤。虽然经蝶窦手术仍然是治疗具有肿块效应的沉默腺瘤的一线方法,但增殖标志物(如KI-67指数)的增加率为了解此类肿瘤的临床过程提供了有用的见解。确定无症状垂体腺瘤的Ki-67指数对于预测初次手术切除后的复发和确定需要额外治疗干预或更频繁的监测成像的风险增加的肿瘤可能有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
31
审稿时长
12 weeks
期刊最新文献
Epidermoid Cyst with Bilateral Premedullary Involvement Resected from Left Far-Lateral Approach. Comment on: Artificial-Intelligent Prediction Model of Occurrence of Cerebral Vasospasms Based on Machine-Learning. Letter to the Editor Regarding "The Effect of Preoperative Cabergoline on Prolactinoma Fibrosis: A Case Series". Microvascular Decompression: An Effective Approach for Trigeminal Neuralgia Caused by a Dolichoectatic Basilar Artery after Multiple Treatment Failures. Immunoglobulin D-Lambda Multiple Myeloma Initially Presenting in the Sphenoid Sinus, Orbital Apex, and Skull Base: A Systematic Review with a Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1